Appropriate primary prevention of cardiovascular disease: Does this mean more or less statin use?

Australian Prescriber

Volumn 34, Issue 6, 2011, Pages 169-172

  Smith, Jane ^a  

^a BOND UNIVERSITY   (Australia)

Author keywords

Antilipidaemic drugs; Cholesterol; HMG CoA reductase inhibitors

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ABORIGINE; ACUTE CORONARY SYNDROME; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; IMMOBILIZATION; ISCHEMIA; MORBIDITY; MORTALITY; OBESITY; PERIPHERAL VASCULAR DISEASE; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIMARY PREVENTION; STROKE;

EID: 82855175379     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2011.085     Document Type: Article

References (18)

1. Australian Institute of Health and Welfare. Australia's health 2010. Canberra: AIHW; 2010.
2. National Vascular Disease Prevention Alliance evidencebased practice guidelines for the assessment of absolute cardiovascular disease risk. Canberra: National Health and Medical Research Council; 2009.
3. Britt H, Miller GC, Charles J, Henderson J, Bayram C, Valenti L, et al. General practice activity in Australia 1999-00 to 2008-09: 10 year data tables. Cat. no. GEP 26. Canberra: Australian Institute of Health and Welfare; 2009.
4. Britt H, Miller GC, Charles J, Valenti L, Fahridin S, Pan Y, et al. General practice activity in Australia 2009-10. General practice series no. 27. Cat. no. GEP 27. Canberra: Australian Institute of Health and Welfare; 2010.
5. Top 10 drugs. Aust Prescr 2011;34:172.
6. Stocks N, Ryan P, Allan J, Williams S, Willson K. Gender, socioeconomic status, need or access? Differences in statin prescribing across urban, rural and remote Australia. Aust J Rural Health 2009;17:92-96.
7. Mitchell JA, Bornstein DB, Sui X, Hooker SP, Church TS, Lee CD, et al. The impact of combined health factors on cardiovascular disease mortality. Am Heart J 2010;160:102-108.
8. Sui X, LaMonte MJ, Blair SN. Cardiorespiratory fitness and risk of nonfatal cardiovascular disease in women and men with hypertension. Am J Hypertens 2007;20:608-615.
9. Civeira F, Ros E, Jarauta E, Plana N, Zambon D, Puzo J, et al. Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia. Am J Cardiol 2008;102:1187-1193.
10. Doll H, Shine B, Kay J, James T, Glasziou P. The rise of cholesterol testing: how much is unnecessary. Br J Gen Pract 2011;61:e81-8.
11. Harris M, Bennett J, Del Mar C, Fasher M, Foreman L, Furler J, et al. Guidelines for preventive activities in general practice. 7th ed. Melbourne: The Royal Australian College of General Practitioners; 2009.
12. Harris MF, Bailey L, Snowdon T, Litt J, Smith JW, Joyner B, et al. Developing the guidelines for preventive care - two decades of experience. Aust Fam Physician 2010;39:63-65.
13. Ray KK, Seshasai SR, Erqou S, Sever P, Jukema JW, Ford I, et al. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med 2010;170:1024-1031.
14. Greving JP, Visseren FL, de Wit GA, Algra A. Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis. BMJ 2011;342:d1672.
15. Taylor F, Ward K, Moore TH, Burke M, Davey Smith G, Casas JP, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2011; 1:CD004816.
16. Hippisley-Cox J, Coupland C. Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. BMJ 2010;340:c2197.
17. Strippoli GF, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, et al. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ 2008;336:645-51.
18. Navaneethan SD, Pansini F, Perkovic V, Manno C, Pellegrini F, Johnson DW, et al. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev 2009;2:CD007784.